HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Sugimura Selected Research

O(6)-(carboxymethyl)-2'-deoxyguanosine

9/2008Detection of endogenous DNA adducts, O-carboxymethyl-2'-deoxyguanosine and 3-ethanesulfonic acid-2'-deoxycytidine, in the rat stomach after duodenal reflux.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Sugimura Research Topics

Disease

51Neoplasms (Cancer)
08/2011 - 01/2002
39Carcinogenesis
08/2011 - 01/2002
17Colonic Neoplasms (Colon Cancer)
10/2007 - 01/2002
11Intestinal Polyps
03/2011 - 09/2002
10Stomach Neoplasms (Stomach Cancer)
01/2012 - 04/2002
10Carcinoma (Carcinomatosis)
10/2006 - 05/2002
9Adenocarcinoma
01/2012 - 01/2002
9Aberrant Crypt Foci
08/2011 - 01/2002
8Polyps
06/2011 - 09/2002
7Hyperlipidemias (Hyperlipidemia)
10/2007 - 09/2003
6Body Weight (Weight, Body)
11/2011 - 06/2003
6Pancreatic Neoplasms (Pancreatic Cancer)
11/2011 - 01/2003
5Genomic Instability
02/2010 - 01/2002
4Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
04/2008 - 07/2003
4Breast Neoplasms (Breast Cancer)
01/2003 - 01/2002
3Infections
01/2012 - 02/2003
3Inflammation (Inflammations)
08/2007 - 08/2004
3Colorectal Neoplasms (Colorectal Cancer)
03/2006 - 03/2005
3Melanoma (Melanoma, Malignant)
02/2005 - 03/2003
2Adenoma (Adenomas)
06/2011 - 05/2002
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2010 - 02/2005
2Lung Neoplasms (Lung Cancer)
09/2009 - 02/2008
2Papilloma (Papillomatosis)
03/2009 - 09/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2009 - 09/2006
2Hyperplasia
08/2008 - 04/2002
2Prostatic Neoplasms (Prostate Cancer)
05/2008 - 04/2005
2Lymphoma (Lymphomas)
08/2007 - 05/2002
2Leukemia
08/2007 - 11/2004
2Gastritis
10/2003 - 02/2003
1Obesity
08/2011

Drug/Important Bio-Agent (IBA)

15Messenger RNA (mRNA)IBA
03/2011 - 01/2002
132- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
09/2009 - 01/2002
12CarcinogensIBA
01/2012 - 01/2002
11AzoxymethaneIBA
08/2011 - 01/2002
11benzocycloheptapyridineIBA
08/2007 - 01/2002
9Proteins (Proteins, Gene)FDA Link
02/2010 - 01/2002
8LipidsIBA
11/2011 - 03/2003
7DNA (Deoxyribonucleic Acid)IBA
05/2006 - 07/2002
6Biological ProductsIBA
01/2007 - 04/2002
6ProstaglandinsIBA
12/2005 - 01/2002
5Poly (ADP-Ribose) Polymerase-1IBA
02/2010 - 02/2005
5Triglycerides (Triacylglycerol)IBA
12/2009 - 09/2003
5NucleotidesIBA
09/2008 - 01/2002
5beta CateninIBA
10/2007 - 01/2002
5Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
12/2005 - 01/2002
5Prostaglandins EIBA
12/2005 - 01/2002
5Methylnitronitrosoguanidine (MNNG)IBA
07/2005 - 06/2002
4AdipokinesIBA
11/2011 - 04/2008
4PPAR gammaIBA
08/2007 - 09/2003
4OligonucleotidesIBA
04/2005 - 07/2002
3nitrosobis(2-oxopropyl)amine (NBOP)IBA
07/2010 - 08/2007
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2008 - 03/2002
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2007 - 09/2003
3PPAR alphaIBA
10/2007 - 09/2003
3Drinking WaterIBA
08/2007 - 10/2003
3Pioglitazone (Actos)FDA Link
08/2007 - 09/2003
3LigandsIBA
08/2007 - 09/2003
3MutagensIBA
01/2007 - 04/2004
3quinolineIBA
05/2006 - 01/2002
3Bromodeoxyuridine (BrdU)IBA
05/2005 - 09/2002
3DecitabineFDA Link
02/2005 - 11/2004
3AntigensIBA
12/2004 - 10/2003
3AminesIBA
07/2003 - 01/2002
2LeptinIBA
11/2011 - 08/2011
2Plasminogen Activators (Plasminogen Activator)IBA
06/2011 - 04/2008
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
12/2009 - 02/2005
2anthraceneIBA
03/2009 - 07/2002
2Urethane (Ethyl Carbamate)IBA
09/2008 - 02/2008
2DNA AdductsIBA
09/2008 - 10/2005
27- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA
08/2008 - 03/2006
2HeptanesIBA
08/2008 - 03/2006
2AndrogensIBA
05/2008 - 04/2005
2Codon (Codons)IBA
02/2008 - 07/2003
2RNA (Ribonucleic Acid)IBA
10/2007 - 05/2004
2Cyclooxygenase 1IBA
10/2006 - 09/2002
2mofezolacIBA
10/2006 - 09/2002
2TeaIBA
04/2006 - 10/2003
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2006 - 10/2003
2ONO 8711IBA
05/2005 - 07/2003
2ThrombomodulinIBA
02/2005 - 11/2002
2Anti-Allergic Agents (Antiallergic Agents)IBA
11/2004 - 11/2004
2FilaminsIBA
08/2004 - 11/2002
2Actin-Related Protein 2-3 Complex (Arp2 3 Complex)IBA
08/2004 - 07/2002
2Poly Adenosine Diphosphate RiboseIBA
12/2003 - 06/2003
22- amino- 3,4- dimethylimidazo(4,5- f)quinoline (MeIQ)IBA
07/2003 - 01/2002
2hydrogen sulfite (bisulfite)IBA
10/2002 - 08/2002
2EnzymesIBA
09/2002 - 01/2002
2nimesulide (Aulin)IBA
09/2002 - 01/2002
2BRCA1 ProteinIBA
08/2002 - 03/2002
2Environmental CarcinogensIBA
07/2002 - 01/2002
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2002 - 01/2002
1indoleIBA
01/2012
1SaltsIBA
01/2012
11-nitrosoindole-3-acetonitrileIBA
01/2012
1Leptin ReceptorsIBA
08/2011
1AMP-Activated Protein KinasesIBA
06/2011

Therapy/Procedure

3Therapeutics
05/2008 - 09/2002
2Injections
06/2011 - 05/2003
2Drug Therapy (Chemotherapy)
02/2010 - 07/2002
2Chemoprevention
02/2005 - 07/2003